Wheeler Bio Announces Closing Of $31 Million Series A Round Supporting Its Clinical (Cgmp) Drug Substance Manufacturing Facility In Oklahoma City
Amount Raised
$31 Million
Round Type
Series A
Oklahoma CityBiotechnologyHealth CareScience And EngineeringInvestors
Description
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round. The round was co-led by Charles River Laboratories (NYSE:CRL) and Echo with participation from ATUM, Floating Point Advisors, Pine Ridge Ventures, Plains Venture Partners (a subsidiary of i2E), Seagull Capital, and Alloy Therapeutics.
Quick answer
Wheeler Bio raised $31 Million in a Series A round, dated April 13, 2023. Investors: Alloy Therapeutics, Seagull Capital, Plains Venture Partners, Pine Ridge Ventures, Floating Point Advisors, That's Nice Llc, Atum and Charles River Laboratories. Wheeler Bio is based in Oklahoma City, Oklahoma, United States.
- How much did Wheeler Bio raise?
- Wheeler Bio raised $31 Million in a Series A round on April 13, 2023.
- Who invested in Wheeler Bio?
- Alloy Therapeutics, Seagull Capital, Plains Venture Partners, Pine Ridge Ventures, Floating Point Advisors, That's Nice Llc, Atum and Charles River Laboratories are named as investors in this round.
- What does Wheeler Bio do?
- Wheeler Bio is a contract development and manufacturing pioneer who has established the ModularCMC™ platform that enables the rapid translation of antibody-based therapeutics from discovery to clinical studies while..
- Where is Wheeler Bio based and how big is it?
- Wheeler Bio is based in Oklahoma City, Oklahoma, United States. Fundz records about 75 employees.
- Who are the decision-makers at Wheeler Bio?
- Fundz holds 1 contact at Wheeler Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Wheeler Bio that raised within 45 days of this round, from Fundz verified event records.
- Ray Therapeutics raised $14M on May 15, 2023.
- Geneos Therapeutics raised $5M (Series A) on April 12, 2023.
- Geneos Therapeutics raised $5M (Series A) on March 31, 2023.
- 22nd Century raised $21M (Debt Financing) on March 3, 2023.
- Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
- Conformal Medical raised $35M on May 26, 2023.
Who to call at Wheeler Bio, and when
A new round usually means Wheeler Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Wheeler Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Wheeler Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Wheeler Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Wheeler Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansWheeler Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.